Both projects involve lots of collaboration, supervision, mentorship and training (& travel!) across our @evomg-dn.bsky.social network. They mandate motility across the #EU and partner countries too. Consequently I think the studentships will offer exceptionally rich #PhD experiences.

The second is about potential fitness costs of cancer drug resistance, and how we might exploit them using approaches like adaptive therapy. (building on our work with @mlockley.bsky.social in ovarian cancer: aacrjournals.org/cancerres/ar...). Description here: www.icr.ac.uk/study-and-ca...

The first is about developing new approaches to track cancer evolution from cell free DNA (cfDNA - liquid biopsy), and is a collaboration with industry partner nonacus.com Description here: www.icr.ac.uk/study-and-ca...

thanks Vijay!

Thanks Christian!

A nice news and views about the paper too: www.nature.com/articles/d41...

Thank you Pavlo Lutsik @kuleuvenuniversity.bsky.social & Veselin Manojlovic, George Vassiliou @cruk-ci.bsky.social

I'm really excited about this work: EVOFLUx tech means we can measure cancer evo at massive scale, even reusing old data. Truly joyful collaboration with brilliant @calumgabbutt.bsky.social Inaki Martin & Marti Duran @idibaps.bsky.social @imperialcollegeldn.bsky.social @qmbci.bsky.social @icr.ac.uk

With the wonderful Inaki Martin-Subero & Marti Duran @idibaps.bsky.social we applied the method (called EVOFLUx) to meth data from ~2000 lymphoid cancers, inferring cancer age, initial growth rate & other evo dynamics. This evolutionary history strongly predicted clinical outcome, especially in CLL.

Schmidt Fellows: if you're a #compbio #AI postdoc, feel free to drop me a line to discuss ideas and I can help you find host labs in the @icr.ac.uk

Postdocs in the USA who'd like to return to Europe to set up their own thing... these could be for you?

www.imperial.ac.uk/jobs/search-...